BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
Clinical trial NCT07583303 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07583303
- Sponsor
- City of Hope Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-14
- Primary completion
- 2027-04-16
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.